Archives for August 13, 2008

← 2008

Sanofi and NovaMed expand distribution deal

By Gareth Macdonald

Sanofi Aventis has extended its deal with China’s NovaMed, adding the anti-convulsant Depakine (valproic acid) to the latter firm’s distribution roster.

Pharmaceutical packaging news in brief

By Nick Taylor

in-PharmaTechnologist.com’s latest round up of developments in the field of pharmaceutical packaging includes 3S’ counterfeit solution and new machines for Xcelience and Medica.

DSM and MorphoSys add MOR202 to Ab deal

By Gareth Macdonald

US-based DSM Biologics and MorphoSys are teaming up to manufacture the MOR202 antibody, which has shown considerable promise as a treatment for multiple myeloma (MM).

CSL snaps up Talecris for $3.1bn

By Phil Taylor

Australia’s CSL Ltd has signed a $3.1bn agreement to acquire Talecris Biotherapeutics of the US and throw down the gauntlet to rival Baxter International in the plasma-based pharmaceutical sector.

DPT secures Nasulin manufacturing deal

By Gareth Macdonald

San Antonio-headquartered manufacturing firm DPT Laboratories has won a long-term contract to produce stocks of CPEX Pharmaceuticals’ candidate intranasal insulin product Nasulin for clinical trials.

Genentech rejects Roche but leaves door ajar

By Nick Taylor

Genentech’s special advisory committee has rejected Roche’s $44bn offer for the biotech believing that it “substantially undervalues” the company.